Aetna in most cases will not pay for the use of power morcellators in myomectomies or hysterectomies, the Hartford, CT–based health insurer said Tuesday.
The new policy goes into effect May 15, an Aetna spokeswoman confirmed to Qmed. The decision comes amid FDA warnings that the spinning blades of the once-popular devices can spread unsuspected uterine sarcoma in the abdomen and pelvis.
Johnson & Johnson’s Ethicon subsidiary already pulled its morcellators from the market last year, including the Gynecare Morcellex Tissue Morcellator, Morcellex Sigma Tissue Morcellator System and the Gynecare X-tract Tissue Morcellator.
Help employers find you! Check out all the jobs and post your resume.
The new policy goes into effect May 15, an Aetna spokeswoman confirmed to Qmed. The decision comes amid FDA warnings that the spinning blades of the once-popular devices can spread unsuspected uterine sarcoma in the abdomen and pelvis.
Johnson & Johnson’s Ethicon subsidiary already pulled its morcellators from the market last year, including the Gynecare Morcellex Tissue Morcellator, Morcellex Sigma Tissue Morcellator System and the Gynecare X-tract Tissue Morcellator.
Help employers find you! Check out all the jobs and post your resume.
